Positron Emission Tomography (PET) imaging rely on a specialized tracer to visualize metabolic activity within the body. This tracer, Fluorodeoxyglucose, is a modified sugar molecule that accumulates in areas of high metabolic demand. By administering FDG into the bloodstream and tracking its distribution through PET scanners, clinicians can observ